Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea

다국어 초록 (Multilingual Abstract)

Background/Aims: The incidence of symptomatic hepatitis A reportedly increased among 20- to 40-year-old Koreanduring the late 2000s. Vaccination against hepatitis A was commenced in the late 1990s and was extended to childrenaged <10 years. In the present study we analyzed the changes in the seroprevalence of IgG anti-hepatitis A virus (HAV)over the past 13 years.
Methods: Overall, 4903 subjects who visited our hospital between January 2001 and December 2013 were studied.
The seroprevalence of IgG anti-HAV was analyzed according to age and sex. In addition, the seroprevalence of IgGanti-HAV was compared among 12 age groups and among the following time periods: early 2000s (2001-2003), midto-late 2000s (2006-2008), and early 2010s (2011-2013). The chi-square test for trend was used for statistical analysis.
Results: The seroprevalence of IgG anti-HAV did not differ significantly between the sexes. Furthermore, comparedto the seroprevalence of IgG anti-HAV in the early 2000s and mid-to-late 2000s, that in the early 2010s was markedlyincreased among individuals aged 1-14 years and decreased among those aged 25-44 years (P<0.01). We also foundthat the seroprevalence of IgG anti-HAV in individuals aged 25-44 years in the early 2010s was lower than that in theearly 2000s and mid-to-late 2000s.
Conclusions: The number of symptomatic HAV infection cases in Korea is decreasing, but the seroprevalence of IgGanti-HAV is low in the active population.

참고문헌 (Reference)

1 송영봉, "한국인 건강검진자에서 연령 특이적 A형간염바이러스 항체 혈청 양성률대한간학회지 제 13 권 제 1 호 2007 ; 27-33" 대한간학회 13 (13): 27-33, 2007

2 이응준, "최근 2년간 발생한 급성 A형간염의 임상 특성에 관한 연구" 대한소화기학회 52 (52): 298-303, 2008

3 김현, "최근 10년간(1988∼1998) 경기지역 소아에서 A형 간염의 역학적 변화 및 임상에 관한 연구" 대한소아감염학회 5 (5): 230-238, 1998

4 이정민, "전투 경찰에서 A형 간염 발생률과 항체 양성률" 대한감염학회 39 (39): 292-295, 2007

5 김태엽, "서울과 경기지역 두 병원의 최근 A형간염 항체 양성률에 대한 비교 조사" 대한간학회 13 (13): 363-369, 2007

6 윤승욱, "대한민국 중부지역의 A형간염 항체양성률, 예방접종률 및 항체생성률" 대한소화기학회 57 (57): 166-172, 2011

7 강형민, "단일 병원에서 경험한 최근 급성 바이러스간염의 원인 및 임상 양상" 대한간학회 13 (13): 495-502, 2007

8 정숙향, "국내 A형간염의 현황과 백신 적응증" 대한소화기학회 51 (51): 331-337, 2008

9 Korea Centers for Disease Control and Prevention, "Statistics of surveillance of hepatitsi A"

10 이현주, "Seroepidemiology of Hepatitis A in Korea: Changes over the Past 30 Years" 대한의학회 26 (26): 791-796, 2011

11 Kim JH., "Recent epidemiological status and vaccination of hepatitis A in Korea" 51 : 110-118, 2008

12 서주윤, "Pattern of Hepatitis A Incidence According to Area Characteristics Using National Health Insurance Data" 대한예방의학회 45 (45): 164-173, 2012

13 Heo JY, "Low level of immunity against hepatitis A among Korean adolescents: vaccination rate and related factors" 41 : e97-e100, 2013

14 Korean Centers of Disease Control & Prevention (CDC), "Hepatitis A Virus"

15 Cho KY., "Hepatitis A" 13 (13): S70-S77, 2010

16 Korea Centers for Disease Control & Prevention, "Guidelines of Vaccination for Adult" Korea Centers for Disease Control & Prevention 2012

17 Nelson KE., "Global changes in the epidemiology of hepatitis A virus infections" 42 : 1151-1152, 2006

18 Jung YK, "Epidemiology and clinical features of acute hepatitis A: from the domestic perspective" 15 : 438-445, 2009

19 Park S, "Epidemiologic study on hepatitis A virus seroprevalence in Busan" 22 : 9-15, 2012

20 Kwon SY., "Current status of liver diseases in Korea: hepatitis A" 15 (15): S7-S12, 2009

21 유선호, "Clinical Features and Risk Factors for Severe Complications among Patients with Acute Hepatitis A Virus Infection in The Jeonbuk Province of Korea" 대한소화기학회 63 (63): 25-31, 2014

22 권소영, "Clinical Characteristics and Outcomes of Acute Hepatitis A in Korea: A Nationwide Multicenter Study" 대한의학회 29 (29): 248-253, 2014

23 Kwon SY., "Changes in clinical characteristics of hepatitis A in Korea" 75 (75): S652-S655, 2008

24 Kim JH, "A survey for seroprevalence of antibody to hepatitis A and development of policy" Korea Centers for Disease Control and Prevention 1-41, 2006

25 Saab S, "A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination" 109 : 241-244, 2000